EMRYX | VEMRX | EMRYX / VEMRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 14 years | - |
Gain YTD | 1.186 | -0.839 | -141% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 397M | 109B | 0% |
Annual Yield % from dividends | 1.55 | 3.48 | 45% |
Returns for 1 year | 4.63 | 13.91 | 33% |
Returns for 3 years | -12.30 | -5.19 | 237% |
Returns for 5 years | -22.02 | 6.00 | -367% |
Returns for 10 years | 5.92 | 29.74 | 20% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DWOCX | 16.01 | 0.17 | +1.07% |
BNY Mellon Research Growth C | |||
FECMX | 38.54 | 0.40 | +1.05% |
Fidelity Advisor Emerging Markets I | |||
NEMAX | 19.87 | 0.18 | +0.91% |
Neuberger Berman Emerg Mkts Eq A | |||
AWWIX | 13.00 | 0.08 | +0.62% |
CIBC Atlas International Growth Instl | |||
CLTCX | 14.90 | 0.09 | +0.61% |
Catalyst/Lyons Tactical Allocation C |